Systemic racism is as real as any disease, and our industry is not immune. This summer, in the wake of a national outcry for racial and social justice, our industry offered a firm stance – systemic racism is a disease. As a pharmacist and public health researcher whose motivation stems from advancing health equity – this statement makes me ponder the question, “How can our industry help break the harmful patterns of racial inequities?” One way PhRMA is advocating for health equity is through a Collaborative Actions to Reach Equity (CAREs) grant.
There’s never been a better time for the pharmaceutical industry to unlock and uncover ways to advance racial equity and address health disparities. The harmful reality is that racial and ethnic health inequities of today are rooted in a painful history. For African Americans and other communities of color, racism is lived day in and day out. From subtle stares and microaggressions while picking your children up from school to overt discriminatory practices, such as redlining and other discriminatory policies, racism in all forms has causative effects on health. For example, structural racism perpetuates the racial wealth gap and segregation of families. Given that access and utilization of health care services and prescription medicines also occur within the power dynamics of race, more research and policies are needed to improve equity in health care delivery.
Through a public health pharmacist lens, advancing equity in medication utilization and adherence is an urgent priority. Given the links between reduced medication adherence and poorer clinical health outcomes, there is an urgency to address root causes of inequity in pharmaceutical care access and delivery across all communities. Ample evidence has demonstrated that Black and Hispanic adults have lower medication utilization and adherence than their white counterparts.
In light of these inequities, PhRMA’s Health Equity Roundtable is offering grants through the CAREs program to solicit solutions that reduce racial and ethnic disparities in medication utilization and adherence.
We are seeking conceptual papers that respond to the following question:
- What are practical, scalable and community-focused approaches to address and ultimately close the gap on racial/ethnic disparities in medication utilization and adherence?
The selected proposal(s) will receive an unrestricted grant from PhRMA for $25,000. Please note that preference will be given to applicants from historically Black colleges and universities, community organizations, faith-based organizations, businesses or academic institutions with a history of providing resources and/or services to communities of color.
Closing the gap on health inequities in medication utilization and adherence requires an all hands-on deck approach. Consider partnering with us to advance multi-faceted solutions that promote equity at every level.
To apply for the PhRMA CAREs Grant, Addressing Racial Disparities in Medication Utilization and Adherence program, applicants must submit a letter of intent by December 14, 2020 at 11:59 PM EST.
To learn more information about eligibility, criteria and how to submit an application please click here.
Learn more about PhRMA’s equity efforts, visit phrma.org/equity.
Jackie McRae
is a Director of Policy, Research, and Membership at PhRMA focusing on health equity and the value of medicines. Jackie graduated with a Doctorate of Pharmacy from Mercer University and Master of Science in Applied Health Economics and Outcomes Research from Thomas Jefferson University. Jackie previously worked as a Post-Doctoral Fellow in Health Economics and Outcomes Research at Janssen Scientific Affairs and Thomas Jefferson University. Outside the office, Jackie can be found hiking on local trails and enjoying scenic drives.
Jackie McRae
Recent events highlight progress on health equity
ICYMI: PhRMA’s 4th Annual Pathways to Success: Virtual STEM Career Expo
Hispanic Heritage Month: Fighting for Hispanic patients
PhRMA awards grants to 2024 Annual Pathways to Success: Virtual STEM Career Expo Partners
How government price setting fails to address systemic health care inequities
Women’s Health Month: A conversation with Sage
Championing cancer equity: Our drive for healthier AANHPI communities
New analysis: Accelerated approval pathway is changing lives in underserved communities
PhRMA provides grant funding to support the Morehouse School of Medicine Satcher Health Leadership Institute’s Health Equity Tra
New social determinants of health simulation explores structural barriers patients face accessing and affording medicines
PhRMA awards grants to 2023 Annual Pathways to Success Graduate Summit Partners
Between hope and despair: Improving cancer outcomes
PhRMA awards grant to Emerson Diversity Health Foundation
PhRMA Otorga Beca a la “Emerson Diversity Health Foundation”
Using traditional HTAs to determine coverage threatens patient access to medicine
Traditional HTAs keep diverse patients out of the conversation
Traditional HTA methods treat everyone like the “average” patient
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities
Potential gene therapies bring hope to patients with sickle cell disease
Stephanie Dyson of BMS on reducing health disparities
Sharing rebates can save Americans with diabetes 500 each year and improve adherence
Announcing CAREs Grant Round 4
Announcing CAREs Grant Round 4
Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda
PhRMA awards $75,000 to fund initiatives to reduce health inequities
Watch: Building trust and enhancing clinical trial diversity
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
PhRMA hosts first stakeholder workshop on clinical trial diversity
PhRMA CAREs Grant request for proposals: Addressing inequities in access to COVID-19 testing, therapeutics and vaccines
PhRMA member companies share how they are improving clinical trial diversity
Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen
Paper finds gaps in health data are a barrier to health equity
New research shows hotspots of inequity relate to increased COVID-19 hospitalizations
Increasing diversity at investigator sites could increase minority participation in clinical trials
Report highlights biopharmaceutical industry’s commitment to D&I
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US
Committing to diversity, equity and inclusion: A call to action for clinical trials
Just released: PhRMA members’ new clinical trial diversity principles
ICYMI: Addressing health inequities: Biopharmaceutical companies are rising to the occasion
Guest Post: Honoring Hispanic Heritage Month by taking action on health equity
Sharing rebates can improve access to medicines and increase health equity
PhRMA will continue to advocate for equity within our industry
Three ways the pharmaceutical industry can positively impact health equity
Guest Post: Amgen Foundation stands for equal opportunities in STEM learning
Systemic racism is as real as any disease, and our industry is not immune
Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month
PhRMA awards $100,000 to fund projects that address health inequalities
Observing National Minority Health Month in the age of COVID-19
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence
Health Equity
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence
PhRMA CAREs Grant request for proposals: Addressing racial disparities in medication utilization and adherence